Handelsbanken Fonder’s Rhythm Pharmaceuticals RYTM Stock Holding History

Handelsbanken Fonder’s Portfolio RYTM Stock Details RYTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.1M	Buy	18,921 +1,400	+8%	+$127K	0.01%	794
2026 Q1	$1.52M	Hold	17,521	–	–	0.01%	853
2025 Q4	$1.88M	Buy	17,521 +2,000	+13%	+$212K	0.01%	763
2025 Q3	$1.57M	Hold	15,521	–	–	0.01%	821
2025 Q2	$981K	Sell	15,521 -1,500	-9%	-$91.8K	﹤0.01%	973
2025 Q1	$902K	Hold	17,021	–	–	﹤0.01%	979
2024 Q4	$953K	Sell	17,021 -2,300	-12%	-$127K	﹤0.01%	989
2024 Q3	$1.01M	Buy	19,321 +3,400	+21%	+$163K	﹤0.01%	947
2024 Q2	$654K	Hold	15,921	–	–	﹤0.01%	1035
2024 Q1	$690K	Buy	15,921 +3,600	+29%	+$158K	﹤0.01%	1009
2023 Q4	$566K	Buy	12,321 +3,500	+40%	+$110K	﹤0.01%	1096
2023 Q3	$202K	Buy	+8,821	New	+$198K	﹤0.01%	1464

Other funds holding RYTM

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Aspiriant LLC Los Angeles, California $4.05B AUM 19.01% 1-Year Est. Return

WCM

Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return

KOCAA

Knights of Columbus Asset Advisors New Haven, Connecticut $2B AUM 42.86% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

CUAMC

China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

AlphaCentric Advisors San Juan, Puerto Rico $118M AUM

Handelsbanken Fonder's RYTM Position: Q2 2026 in Review

Handelsbanken Fonder increased its Rhythm Pharmaceuticals (RYTM) stake by 8% in Q2 2026, buying an estimated $127K and bringing the position to 18,921 shares worth $2.1M. The position accounts for 0.01% of the portfolio, ranked #794.

Handelsbanken Fonder first reported a position in RYTM in Q3 2023 and has held it in 12 quarters since. 52 funds tracked by Wall St. Rank hold RYTM as of Q2 2026.

Handelsbanken Fonder held 18,921 shares of Rhythm Pharmaceuticals worth $2.1M as of Q2 2026.
Handelsbanken Fonder bought 1,400 Rhythm Pharmaceuticals shares in Q2 2026, an estimated $127K.
Rhythm Pharmaceuticals made up 0.01% of Handelsbanken Fonder's portfolio in Q2 2026, its #794 holding.
Handelsbanken Fonder first reported a position in Rhythm Pharmaceuticals in Q3 2023 and has held it in 12 quarters since.
52 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2026.

Based on Handelsbanken Fonder's 13F filing for Q2 2026, filed 10 Jul 2026.